Literature DB >> 9342212

The structure, regulation and function of the Janus kinases (JAKs) and the signal transducers and activators of transcription (STATs).

S Pellegrini1, I Dusanter-Fourt.   

Abstract

Since the discovery of their physiological roles in cytokine signalling, the Janus kinases (JAKs) and the signal transducers and activators of transcription (STATs) have attracted considerable attention, to the point that the concept of a intracellular signalling pathway, named JAK/STAT, has emerged. As originally defined, this pathway involves ligand-dependent activation of a particular class of receptor-associated tyrosine kinases, the JAK proteins, which phosphorylate themselves and receptor components, creating recruitment sites for STAT transcription factors. The STATs are phosphorylated, they dissociate from the receptor x JAK complex and translocate to the nucleus where they participate in transcriptional gene activation. Although this pathway was found initially to be activated by interferons, it is now known that a large number of cytokines, growth factors and hormonal factors activate JAK and/or STAT proteins. Recent findings have suggested that the interdependence of JAKs and STATs might not be absolute as originally thought.

Mesh:

Substances:

Year:  1997        PMID: 9342212     DOI: 10.1111/j.1432-1033.1997.00615.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  54 in total

1.  A nuclear protein tyrosine phosphatase is required for the inactivation of Stat1.

Authors:  R L Haspel; J E Darnell
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

2.  A single amino acid substitution (Trp(666)-->Ala) in the interbox1/2 region of the interleukin-6 signal transducer gp130 abrogates binding of JAK1, and dominantly impairs signal transduction.

Authors:  C Haan; H M Hermanns; P C Heinrich; I Behrmann
Journal:  Biochem J       Date:  2000-07-01       Impact factor: 3.857

3.  Structural requirements of the interleukin-6 signal transducer gp130 for its interaction with Janus kinase 1: the receptor is crucial for kinase activation.

Authors:  Claude Haan; Peter C Heinrich; Iris Behrmann
Journal:  Biochem J       Date:  2002-01-01       Impact factor: 3.857

4.  Cytokine G-protein signaling crosstalk in cardiomyocytes: attenuation of Jak-STAT activation by endothelin-1.

Authors:  George W Booz; Jonathan N E Day; Robert Speth; Kenneth M Baker
Journal:  Mol Cell Biochem       Date:  2002-11       Impact factor: 3.396

Review 5.  Signaling of cytokines is important in regulation of GnRH neurons.

Authors:  Sheng Wu; Andrew Wolfe
Journal:  Mol Neurobiol       Date:  2011-12-13       Impact factor: 5.590

6.  Dietary compounds as potent inhibitors of the signal transducers and activators of transcription (STAT) 3 regulatory network.

Authors:  Anne Trécul; Franck Morceau; Mario Dicato; Marc Diederich
Journal:  Genes Nutr       Date:  2012-01-25       Impact factor: 5.523

7.  Daphnetin reduces endotoxin lethality in mice and decreases LPS-induced inflammation in Raw264.7 cells via suppressing JAK/STATs activation and ROS production.

Authors:  Lei Shen; Ting Zhou; Jing Wang; Xiumei Sang; Lei Lan; Lan Luo; Zhimin Yin
Journal:  Inflamm Res       Date:  2017-04-13       Impact factor: 4.575

Review 8.  Janus kinases and focal adhesion kinases play in the 4.1 band: a superfamily of band 4.1 domains important for cell structure and signal transduction.

Authors:  J A Girault; G Labesse; J P Mornon; I Callebaut
Journal:  Mol Med       Date:  1998-12       Impact factor: 6.354

Review 9.  Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.

Authors:  P C Heinrich; I Behrmann; G Müller-Newen; F Schaper; L Graeve
Journal:  Biochem J       Date:  1998-09-01       Impact factor: 3.857

10.  Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1.

Authors:  R Starr; D Metcalf; A G Elefanty; M Brysha; T A Willson; N A Nicola; D J Hilton; W S Alexander
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.